JPH02279671A - Production of 1,4-dimethylcarbazole derivative - Google Patents
Production of 1,4-dimethylcarbazole derivativeInfo
- Publication number
- JPH02279671A JPH02279671A JP9844289A JP9844289A JPH02279671A JP H02279671 A JPH02279671 A JP H02279671A JP 9844289 A JP9844289 A JP 9844289A JP 9844289 A JP9844289 A JP 9844289A JP H02279671 A JPH02279671 A JP H02279671A
- Authority
- JP
- Japan
- Prior art keywords
- dimethylcarbazole
- derivative
- ion exchange
- exchange resin
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- APYQRKDHRDGCBK-UHFFFAOYSA-N 1,4-dimethyl-9h-carbazole Chemical class N1C2=CC=CC=C2C2=C1C(C)=CC=C2C APYQRKDHRDGCBK-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 239000002253 acid Substances 0.000 claims abstract description 15
- OJVAMHKKJGICOG-UHFFFAOYSA-N 2,5-hexanedione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 claims abstract description 10
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 8
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 8
- 150000002475 indoles Chemical class 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 4
- CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000011282 treatment Methods 0.000 abstract description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract description 3
- 230000000259 anti-tumor effect Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract description 2
- JYCYJKQLGQKTRX-UHFFFAOYSA-N 6-methoxy-1,4-dimethyl-9h-carbazole Chemical compound C1=CC(C)=C2C3=CC(OC)=CC=C3NC2=C1C JYCYJKQLGQKTRX-UHFFFAOYSA-N 0.000 abstract 1
- ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 abstract 1
- SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000002904 solvent Substances 0.000 description 7
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- BOCODUXWXDKEJP-UHFFFAOYSA-N 1,2-dimethyl-9h-carbazole Chemical class C1=CC=C2C3=CC=C(C)C(C)=C3NC2=C1 BOCODUXWXDKEJP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LUNOXNMCFPFPMO-UHFFFAOYSA-N 4-methoxy-1h-indole Chemical compound COC1=CC=CC2=C1C=CN2 LUNOXNMCFPFPMO-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- -1 turmix Chemical compound 0.000 description 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- QHXKZUNCOGOKRX-UHFFFAOYSA-N 1-benzyl-3h-indol-2-one Chemical compound O=C1CC2=CC=CC=C2N1CC1=CC=CC=C1 QHXKZUNCOGOKRX-UHFFFAOYSA-N 0.000 description 1
- MALZYBOXBVXCSN-UHFFFAOYSA-N 11h-pyrido[3,2-a]carbazole Chemical group C1=CC2=NC=CC=C2C2=C1C1=CC=CC=C1N2 MALZYBOXBVXCSN-UHFFFAOYSA-N 0.000 description 1
- NKROKGXCQINQQK-UHFFFAOYSA-N 2,3-dimethoxy-1h-indole Chemical compound C1=CC=C2C(OC)=C(OC)NC2=C1 NKROKGXCQINQQK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- VZPAFQARWUBWIU-UHFFFAOYSA-N 4-benzyl-1,3-dihydroindol-2-one Chemical compound N1C(=O)CC2=C1C=CC=C2CC1=CC=CC=C1 VZPAFQARWUBWIU-UHFFFAOYSA-N 0.000 description 1
- DWAQDRSOVMLGRQ-UHFFFAOYSA-N 5-methoxyindole Chemical compound COC1=CC=C2NC=CC2=C1 DWAQDRSOVMLGRQ-UHFFFAOYSA-N 0.000 description 1
- HWTDMFJYBAURQR-UHFFFAOYSA-N 80-82-0 Chemical compound OS(=O)(=O)C1=CC=CC=C1[N+]([O-])=O HWTDMFJYBAURQR-UHFFFAOYSA-N 0.000 description 1
- BKRMCDAOAQWNTG-UHFFFAOYSA-N 9-methoxy-5,11-dimethyl-6h-pyrido[4,3-b]carbazole Chemical compound C1=NC=C2C(C)=C(C=3C(=CC=C(C=3)OC)N3)C3=C(C)C2=C1 BKRMCDAOAQWNTG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 208000007093 Leukemia L1210 Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- OKZIUSOJQLYFSE-UHFFFAOYSA-N difluoroboron Chemical compound F[B]F OKZIUSOJQLYFSE-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- FZJCXIDLUFPGPP-UHFFFAOYSA-N propan-2-ol;toluene Chemical compound CC(C)O.CC1=CC=CC=C1 FZJCXIDLUFPGPP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
・〔産業上の利用分野〕
本発明は1.4−ジメチルカルバゾール誘導体、更に詳
細には、抗1liIi瘍作用を有するエリブティシン誘
導体の合成中間体としてイi’ Jlな次の一般式(1
)
(式中、R1及び11は水素原子、低級丁ル」キシ基又
は保護されていてもよい水酸基を示す)
で表わされる1、4−ジメチルカルバゾール誘導体の新
規な製造法に関する。Detailed Description of the Invention - [Field of Industrial Application] The present invention is directed to the use of 1,4-dimethylcarbazole derivatives, more specifically, as intermediates for the synthesis of eribticin derivatives having anti-1liIi tumor activity. The general formula (1
) (In the formula, R1 and 11 represent a hydrogen atom, a lower dimethyloxy group, or an optionally protected hydroxyl group.)
ピリドカルバゾール骨格を有するエリプディシン誘導体
(特開昭61−377!19号)には抗腫瘍活性を有す
る化合物が多く、例えば、2N−メチル−9−ヒドロキ
シエリブティニウムアセテートが乳癌に対して有効であ
り〔口ull、 Cancer(Paris) 6
8. 437 〜441(1981)] 、エリブティ
シン及び9−メトキシエリプティシンは実験動物+rt
瘍であるマウス白血病L −1210やサルコー718
0 (Sarcoma180、固型)に対し活性を持
つ[J、 Mad、 lem。Many ellipdicine derivatives having a pyridocarbazole skeleton (Japanese Unexamined Patent Publication No. 61-377!19) have antitumor activity; for example, 2N-methyl-9-hydroxyeributinium acetate is effective against breast cancer. Yes [mouth ull, Cancer (Paris) 6
8. 437-441 (1981)], eributicin and 9-methoxyellipticin were used in experimental animals + rt
Mouse leukemia L-1210 and Sarco 718
0 (Sarcoma180, solid) [J, Mad, lem.
18、755〜760 (1975)]ことが報告され
る。18, 755-760 (1975)].
而して、エリプティシン誘導体は、例えばAu5t、
J、 Che[I+、20.2715〜2’?27(1
907);J。Thus, ellipticine derivatives include, for example, Au5t,
J, Che[I+, 20.2715~2'? 27 (1
907);J.
Che+n、Soc、 Perkin 1,1698〜
1704(1977);Tetrahedron Le
ft、、 1261〜1264 (1!17B) ;
ヨーロッパ特許明細書第9445号明細書などに記載さ
れているように、1.4−ジメチルカルバゾール誘導体
より導かれる。このため1. 4−ジメチルカルバソー
ル誘導体はエリブディシン誘導体の合成中間体として有
用な化合物である。Che+n, Soc, Perkin 1,1698~
1704 (1977); Tetrahedron Le
ft,, 1261~1264 (1!17B);
As described in European Patent Specification No. 9445, etc., it is derived from a 1,4-dimethylcarbazole derivative. For this reason, 1. 4-dimethylcarbasol derivatives are useful compounds as synthetic intermediates for eribdicine derivatives.
従来、1.4−ジメチルカルバゾール誘導体を製造する
方法としては、インドール誘導体と2.5−ヘキサンジ
オンとを、エタノール、ジオキサンなどの溶媒中、塩酸
ガス、p−1ルエンスルホン酸、ミフッ化ホウ素エーテ
ル錯体などの強酸を触媒として用いて反応させる方法が
知られている。Conventionally, as a method for producing 1,4-dimethylcarbazole derivatives, an indole derivative and 2,5-hexanedione are mixed in a solvent such as ethanol or dioxane with hydrochloric acid gas, p-1 luenesulfonic acid, or boron difluoride ether. A method of reacting using a strong acid such as a complex as a catalyst is known.
しかしながら、斯かる従来法は、強酸をそのまま使用す
るため、タールなどが多mに生成し、J、 Chem、
Sac、 1962.3482では1. /1−ジ
メチルカルバゾールを36%の収率で、また^ust、
J、 Chew、、 20.2715(19G?)では
6−メドキシー1.4−ジメチルカルバゾールを38%
の収率で得ているにすぎず、極めて低収率であった。し
かし、原料のインドール誘導体は工業試薬としては市販
され°Cいない高価なものであり、しかもこれを製造−
→−ろには多くの工程を必要とするため、上記工程の低
収率はエリプティシン誘導体の”A 4における隘路と
なっていた。However, since such conventional methods use strong acids as they are, a large amount of tar etc. is generated, and J. Chem.
Sac, 1962.3482 1. /1-dimethylcarbazole in 36% yield, and
J, Chew, 20.2715 (19G?) contains 38% 6-medoxy 1,4-dimethylcarbazole
The yield was extremely low. However, the indole derivative used as a raw material is not commercially available as an industrial reagent and is expensive.
The low yield of the above steps has been a bottleneck in the production of ellipticine derivatives since many steps are required.
斯かる実状において、本ざぎ1■者は上記問題点を解決
せんと鋭意研究を行った結果、触媒として、ピリジル基
を有するイオン交換樹脂の酸付加塩を使用して、インド
ール誘導体と2.5−ヘキサンジオンを反応せしめれば
極めて高収率で1.4−ジメチルカルバゾール誘導体(
1)が得られることを見出し、本発明を完成した。Under such circumstances, Honzagi 1 conducted intensive research to solve the above problems, and as a result, using an acid addition salt of an ion exchange resin having a pyridyl group as a catalyst, the indole derivative and 2.5 -1,4-dimethylcarbazole derivative (1,4-dimethylcarbazole derivative (
It was discovered that 1) could be obtained, and the present invention was completed.
本発明方法は次の反応式によっCホされる。The method of the present invention is carried out by the following reaction formula.
(式中、R,及びlζ、は前記と1ム1じ)すなわち、
本発明は、インドール誘導体(II)と2.5−ヘキサ
ンジオン(1u)とを、ピリジル基を有するイオン交換
樹11けの酸付加塩の存在下反応せしめて1.4−・−
ジメチルカルバゾール誘導体(1)を製造する方法であ
る。(In the formula, R and lζ are the same as above) That is,
The present invention provides 1.4-.-
This is a method for producing dimethylcarbazole derivative (1).
本発明で使用される触媒のピリジル基を有するイオン交
換樹脂の酸付加塩と1−ては、分子中に次式(IV)
(式中、X 11酸アニ」ンを示す)
で表わされる構、造単位をもつものが挙げられる。この
ような樹脂は例えば広栄化学q勾社からKBK−316
として市販されている。また、×。The acid addition salt of the ion exchange resin having a pyridyl group of the catalyst used in the present invention has a structure in the molecule represented by the following formula (IV) (wherein X represents an anionic acid 11). , and those with structural units. Such a resin is, for example, KBK-316 from Koei Kagaku QKosha.
It is commercially available as. Also, x.
で表わされる酸アニツ゛ンとして1!、塩酸、臭化水素
酸、硫酸、四フッ化ホウ素水素酸等の強無機酸;メタン
スルホン酸、ベンゼンスフレホンR1p−)ルエンスル
ホン酸、ニトロベンゼンスルホン酸等の残有!a酸のア
ニオンが好ましい。これらの触媒は、通・11古原料の
インドール誘導体の0.5〜4.(j倍モルを使用する
のが好ましい。As the acid anidine represented by 1! , strong inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, and hydrogen tetrafluoroboric acid; residual presence of methanesulfonic acid, benzenesuflephone R1p-) luenesulfonic acid, nitrobenzenesulfonic acid, etc.! The anion of the a acid is preferred. These catalysts contain 0.5-4. (It is preferable to use j times the molar amount.
本発明方法は、メタノール、エタノール、ツルミックス
、イソプロピルアルコールルエン、ジオキサン、アセト
ニトリル、ジグライム等の反応に関与しない溶媒中、6
0〜150℃の温度で、20−100時間反応させるこ
とによって実施される。The method of the present invention involves the use of 6 ml of alcohol in a solvent that does not participate in the reaction, such as methanol, ethanol, turmix, isopropyl alcohol toluene, dioxane, acetonitrile, diglyme, etc.
It is carried out by reacting for 20-100 hours at a temperature of 0-150°C.
反応後、反応混合物から樹脂触媒を濾別し、濾液から溶
媒を留去すれば1.4−ジメチルカルバゾール誘導体(
1)の粗結晶が得られるので、強酸をそのまま触媒とし
て使用する従来法のような、抽出、水洗等の煩雑な後処
理を必要としない。また、回収した触媒はそのまま次の
反応に再使用できる。After the reaction, the resin catalyst is filtered from the reaction mixture, and the solvent is distilled off from the filtrate to obtain the 1,4-dimethylcarbazole derivative (
Since the crude crystals of 1) are obtained, there is no need for complicated post-treatments such as extraction and water washing, which are required in conventional methods that use strong acids as they are as catalysts. In addition, the recovered catalyst can be reused as is for the next reaction.
叙上の如く、本発明は極めて収率がよいと共に、後処理
が簡単であり、しかも回収した触媒は次の反応に再使用
できるので経済的であるなどの種々の利点を有する。As mentioned above, the present invention has various advantages such as extremely high yield, easy post-treatment, and economical since the recovered catalyst can be reused in the next reaction.
次に実施例を挙げて説明する。 Next, an example will be given and explained.
実施例1
ピリジン型イオン交換樹脂〔広栄化学番幼製、に口X−
316]の]p−トルエンスルホン酸塩6.8ミリ当量
相当)を5−メトキシインドール500 mg (3,
4ミリモル)、215−ヘキサンジオン542 mg
(4,8ミリモル)、エタノール2.5−の混液中に加
え、72時間加熱還流した。熱時に樹脂を姉別し、エタ
ノールで洗浄した。濾洗液を合し、減圧下溶媒留去して
得た残渣をシリカゲルクロマトグラフィー(溶媒ニジク
ロロメタン)にてfi’i ’M L、6−メト、キシ
−1,4−ジメチルカルバソ′−ルを612mg得た(
インドールに対する収率80%)。Example 1 Pyridine type ion exchange resin [Koei Kaban Yosei, Niguchi X-
316] p-toluenesulfonate (equivalent to 6.8 meq.) was mixed with 500 mg of 5-methoxyindole (3,
4 mmol), 215-hexanedione 542 mg
(4.8 mmol) was added to a mixture of 2.5 mm of ethanol and heated under reflux for 72 hours. The resin was separated while hot and washed with ethanol. The filtration and washing liquids were combined and the solvent was distilled off under reduced pressure. The resulting residue was purified by silica gel chromatography (solvent: dichloromethane) to obtain fi'i'M L, 6-meth, xy-1,4-dimethylcarbaso'- Obtained 612 mg of
80% yield based on indole).
融点 136.5〜137.0 ℃
実施例2〜5
実施例1のエタノールの代りに第1表の溶媒を使用する
以外は同様に操作し、第1表に示す収率で6−メドキシ
ー1.4−ジメチルカルバゾールを得た。Melting point 136.5-137.0°C Examples 2-5 6-Medoxy 1. 4-dimethylcarbazole was obtained.
第1表
第2表
実施例6〜11
実施例1のイオン交換樹脂のp−トルエンスルホン酸塩
の代りに第2表の酸塩を使用する以外は同様に操作して
、第2表に示す収率で6−メドキシー1.4−ジメチル
カルバソ′−ルを得た。Table 1 Table 2 Examples 6 to 11 The results are shown in Table 2 in the same manner except that the acid salts in Table 2 were used in place of the p-toluenesulfonate of the ion exchange resin in Example 1. A yield of 6-medoxy 1,4-dimethylcarbasol was obtained.
以下余白
実施例12
インドール5.0g (42,7ミリモル) 2゜
5−へ牛サンジオン6−8 g (59,6ミリモル
)及ヒに0X−316・p−)ルエンスルホン酸塩(4
2,8ミリモル相当)をエタノール25mN中に加え、
20時間加熱還流した。熱時に樹脂を濾去し、エタノー
ルで洗浄した1、濾洗液を合し、減圧上溶媒を留去して
(4また残渣をシリカゲルクロマトグラフィー(溶媒二
りロロホルム)1こで精製して、1.4−ジメチルカル
バゾールを6.7g得た(インドールに対する収率80
%)。Below are blank spaces Example 12 5.0 g (42.7 mmol) of indole, 6-8 g (59.6 mmol) of bovine sandione and 0X-316 p-) luenesulfonate (4
2.8 mmol equivalent) in 25 mN ethanol,
The mixture was heated under reflux for 20 hours. The resin was filtered off while hot and washed with ethanol. 1. The filtrate and washing liquid were combined and the solvent was distilled off under reduced pressure (4. The residue was purified by silica gel chromatography (solvent dichloroform) 1. 6.7g of 1,4-dimethylcarbazole was obtained (yield 80% based on indole).
%).
融点9765〜98.0℃
実施例13
4−メトキシインドール545 mg (3,7ミリモ
ル)、2.5−ヘキサンジオンf、1g(9,6ミIJ
モル)及びKl!X−316・p −) ルxンスル
ホン酸塩(3,7ミリ当量相当)をエタノール10社中
に加え、38時間加熱還流した。実施例12と同様に処
理して5−メトキシ−1,4−ジメチルカルバゾールを
56211Ig得た(4−メトキシインドールに対する
収率67%)。Melting point 9765-98.0°C Example 13 4-methoxyindole 545 mg (3,7 mmol), 2,5-hexanedione f, 1 g (9,6 mmol)
mole) and Kl! X-316.p-) Luxunsulfonate (equivalent to 3.7 milliequivalents) was added to ethanol 10 and heated under reflux for 38 hours. The same treatment as in Example 12 was carried out to obtain 56211 Ig of 5-methoxy-1,4-dimethylcarbazole (yield 67% based on 4-methoxyindole).
融点 135.0℃
実施例14
4−ベンジルオキシインドール5、Og(22,4ミリ
モル)、2.5−ヘキサンジオン3.6g<31.6ミ
U %ル)及びK[!X−316−p −) ルxンス
ルホン酸塩(22,4ミリ当量相当)をエタノール2S
rnl中に加え、3B、5時間加熱還流した。実施例1
2と同様に処理して5 ベンジルt =)−シー1.4
−ジメチルカルバゾールを4.1 g 14り< 4−
ベンジルオキシインドールに対する収率01%)。Melting point 135.0°C Example 14 4-benzyloxindole 5, Og (22.4 mmol), 2.5-hexanedione 3.6 g < 31.6 mmol) and K[! X-316-p -) Luxunsulfonate (equivalent to 22,4 meq.
rnl and heated under reflux for 5 hours under 3B. Example 1
Treated in the same manner as in 2 to obtain 5 benzyl t =) - C 1.4
-4.1 g of dimethylcarbazole < 4-
Yield 01% based on benzyloxindole).
融点 129.5℃
実施例15
5.6−シメトキシインドール1.(]に(5,fiミ
リモル) 、2 + 5−ヘキづンジ」ンt1.!l
ル(7,9ミリモル)及びにUX−31ti ・l)
l−ル、T−ンスルホン酸塩(5,7ミリ当[d札1
当)をエタノールlロー中に加え、35.5時間加熱還
流した。Melting point 129.5°C Example 15 5.6-Simethoxyindole 1. (] to (5, fi mmol), 2 + 5-hekidzinjin t1.!l
(7,9 mmol) and UX-31ti・l)
l-ru, T-sulfonate (5.7 milliliters [d tag 1
The mixture was added to 1 liter of ethanol and heated under reflux for 35.5 hours.
実施例12と同様に処理しでf3,7−シメトキシー1
4−ジメチルカルバゾール峻(1,78得たく5.6−
ジメトキシインドールに対する収率49%)。f3,7-cymethoxy 1 was treated in the same manner as in Example 12.
4-dimethylcarbazole (1,78%, 5.6-
Yield 49% based on dimethoxyindole).
融点 IBl、9℃ 以 上Melting point IBL, 9℃ that's all
Claims (1)
基又は保護されていてもよい水酸基を示す) で表わされるインドール誘導体と2,5−ヘキサンジオ
ンとを、ピリジル基を有するイオン交換樹脂の酸付加塩
の存在下反応せしめることを特徴とする一般式( I ) ▲数式、化学式、表等があります▼ (式中、R_1及びR_2は前記と同じ) で表わされる1,4−ジメチルカルバゾール誘導体の製
造法。[Claims] 1. General formula (II) ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (II) (In the formula, R_1 and R_2 represent a hydrogen atom, a lower alkoxy group, or an optionally protected hydroxyl group) General formula (I) characterized by reacting an indole derivative represented by ) with 2,5-hexanedione in the presence of an acid addition salt of an ion exchange resin having a pyridyl group. A method for producing a 1,4-dimethylcarbazole derivative represented by ▼ (wherein R_1 and R_2 are the same as above).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9844289A JPH02279671A (en) | 1989-04-18 | 1989-04-18 | Production of 1,4-dimethylcarbazole derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9844289A JPH02279671A (en) | 1989-04-18 | 1989-04-18 | Production of 1,4-dimethylcarbazole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02279671A true JPH02279671A (en) | 1990-11-15 |
Family
ID=14219876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9844289A Pending JPH02279671A (en) | 1989-04-18 | 1989-04-18 | Production of 1,4-dimethylcarbazole derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02279671A (en) |
-
1989
- 1989-04-18 JP JP9844289A patent/JPH02279671A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63275582A (en) | Production of 1-aminoimidazo(4,5-b)pyridine derivative | |
EP1687310B1 (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
AU2003290629B2 (en) | Method for the catalytic production of hydrocodone and hydromorphone | |
ES2249830T3 (en) | PROCEDURES AND INTERMEDIATE PRODUCTS TO PREPARE STEREOISOMEROS OF PIPERIDINES 2-REPLACED. | |
JPS60152499A (en) | Manufacture of alpha-l-aspartyl-l- phenylalninemethyl ester | |
JPH02279671A (en) | Production of 1,4-dimethylcarbazole derivative | |
JPS63196573A (en) | Quinazolineacetic acid derivative | |
JP2002517399A (en) | Novel vinca alkaloid derivative and method for its preparation | |
US4076724A (en) | Polycyclic macrocyclic compounds | |
US4031108A (en) | 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane | |
US4450274A (en) | Preparation of ethambutol-diisoniazide methane sulfonic acid salt | |
CN112778189A (en) | (3R,4S) -N-substituent-3-carboxylic acid-4-ethyl pyrrolidine, intermediate and lapatinib | |
JP3010264B2 (en) | Method for producing isocoumarins | |
CN112574106B (en) | Synthesis method of 7-amino-5-bromoquinoline | |
JP2860676B2 (en) | Method for producing 1-isoquinolines | |
JP2736916B2 (en) | Manufacturing method of cibeton | |
US4011231A (en) | 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate | |
JP2767287B2 (en) | Indole production method | |
US5625065A (en) | Stereoselective process for making endo-tropanamine and like compounds | |
JPH04368377A (en) | 4-amino-3-hydroxyphthalide and method for manufacturing same | |
JP2571939B2 (en) | Cyclopentenone derivatives and their production | |
JPH0273060A (en) | Preparation of indole compound | |
JP2782457B2 (en) | Method for producing indole | |
JPH02188591A (en) | 2-(diphenylphosphino)-cycloalkane derivative, production thereof and catalyst for asymmetric synthesis | |
JPS59186963A (en) | Novel phenylpiperazine derivative |